BackKissei Pharmaceutical , Ltd. Overview

Kissei Pharmaceutical , Ltd. Inventory

Track Kissei Pharmaceutical , Ltd.'s inventory ($26B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$25.62B
↑ 1.95% YoYΔ $490.41M vs prior year quarter

Peer trimmed avg / median

Loading

Kissei Pharmaceutical , Ltd. Inventory History

Loading

Kissei Pharmaceutical , Ltd. vs. peers: Inventory Comparison

Loading

Kissei Pharmaceutical , Ltd. Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Kissei Pharmaceutical , Ltd. (KSPHF) FAQ

As of the most recent data (June 2026), KSPHF shows a inventory of $26B. That compares with $25B in the prior-year period — up 2.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, KSPHF's inventory is now $26B (was $25B) — a 2.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Kissei Pharmaceutical , Ltd. is outperforming or lagging.

Tracking KSPHF's inventory over time shows whether Kissei Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $26B That compares with $25B in the prior-year period — up 2.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Kissei Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $26B) with ownership activity and broader fundamentals.